Files
2026-07-06 17:28:36 -04:00

7.2 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Health insurance; if prior authorization request is approved for prescription drugs. Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered. This bill is identical to HB 1134. us/states/va Virginia General Assembly 2024 SB 98 Virginia SB 98 (2024)
bill
enacted
Barbara A. Favola
4 33 6 2024-01-02 2024-04-02 openstates ocd-bill/30ff2f8e-54e8-422c-9041-f6fe858cbf1d https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+SB98 1b5fcb469f48e1c51831ec4c2c141009cde99574c81026ed613421dc71c9bcb8 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia SB 98 (2024) — Health insurance; if prior authorization request is approved for prescription drugs.

Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered. This bill is identical to HB 1134.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. CHAP0338 (committee substitute) — source
  2. Committee substitute printed 24105929D-S1 (committee substitute) — source
  3. Prefiled and ordered printed; offered 01/10/24 24101001D (committee substitute) — source
  4. SB98ER (committee substitute) — source

Votes

  • Reported from Labor and Commerce with amendment(s) (22-Y 0-N) — 220 (pass) · lower
  • VOTE: Block Vote Passage (98-Y 0-N) — 970 (pass) · lower
  • Read third time and passed Senate (38-Y 0-N) — 380 (pass) · upper
  • House amendment agreed to by Senate (39-Y 0-N) — 390 (pass) · upper
  • Constitutional reading dispensed (40-Y 0-N) — 400 (pass) · upper
  • Reported from Commerce and Labor with substitute (15-Y 0-N) — 150 (pass) · upper

Sponsors

  • Barbara A. Favola — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2024-01-02 Prefiled and ordered printed; offered 01/10/24 24101001D filing, introduction
  • 2024-01-02 Referred to Committee on Commerce and Labor referral-committee
  • 2024-01-22 Senate committee, floor amendments and substitutes offered
  • 2024-01-22 Reported from Commerce and Labor with substitute (15-Y 0-N) committee-passage
  • 2024-01-22 Committee substitute printed 24105929D-S1 substitution
  • 2024-01-24 Impact statement from SCC (SB98)
  • 2024-01-24 Constitutional reading dispensed (40-Y 0-N)
  • 2024-01-25 Read second time reading-2
  • 2024-01-25 Reading of substitute waived
  • 2024-01-25 Committee substitute agreed to 24105929D-S1 substitution
  • 2024-01-25 Engrossed by Senate - committee substitute SB98S1 substitution
  • 2024-01-26 Read third time and passed Senate (38-Y 0-N) passage, reading-3
  • 2024-01-29 Impact statement from SCC (SB98S1)
  • 2024-02-13 Placed on Calendar
  • 2024-02-13 Read first time reading-1
  • 2024-02-13 Referred to Committee on Labor and Commerce referral-committee
  • 2024-02-20 Reported from Labor and Commerce with amendment(s) (22-Y 0-N) committee-passage
  • 2024-02-22 Read second time reading-2
  • 2024-02-23 Read third time reading-3
  • 2024-02-23 Committee amendment agreed to amendment-passage
  • 2024-02-23 Engrossed by House as amended
  • 2024-02-23 Passed House with amendment BLOCK VOTE (98-Y 0-N) passage
  • 2024-02-23 VOTE: Block Vote Passage (98-Y 0-N) passage
  • 2024-02-27 House amendment agreed to by Senate (39-Y 0-N) amendment-passage
  • 2024-03-04 Enrolled enrolled
  • 2024-03-04 Bill text as passed Senate and House (SB98ER) passage
  • 2024-03-04 Signed by Speaker passage
  • 2024-03-07 Signed by President passage
  • 2024-03-08 Impact statement from SCC (SB98ER)
  • 2024-03-11 Enrolled Bill Communicated to Governor on March 11, 2024 enrolled
  • 2024-03-11 Governor's Action Deadline 11:59 p.m., April 8, 2024 executive-receipt
  • 2024-04-02 Approved by Governor-Chapter 338 (effective 7/1/24) executive-signature
  • 2024-04-02 Acts of Assembly Chapter text (CHAP0338)

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/30ff2f8e-54e8-422c-9041-f6fe858cbf1d. Confidence: reported (aggregated from official Virginia legislature records).